Effect of High-intensity Interval Training Combined With DASH Diet on Arterial Stiffness in Hypertensive Patients
1 other identifier
interventional
20
1 country
1
Brief Summary
Cardiovascular disease (CVD) is one of the leading causes of mortality worldwide and a major risk factor for morbidity worldwide . It is necessary to reduce the incidence and risk factors of CVD, as physical activity is known to reduce mortality from CVD. Arterial stiffness and hypertension are closely related in pathophysiology. Chronic high blood pressure (BP) can lead to arterial wall damage by mechanical stress, endothelial dysfunction, increased inflammation, oxidative stress, and renin-angiotensin-aldosterone system (RAAS) activation. HIIT has been shown to be equally or even better at stimulating health benefits than moderate-intensity continuous training (MICT) and is considered a time-saving aerobic exercise for reducing arterial stiffness in HTN patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Jul 2025
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2025
CompletedFirst Submitted
Initial submission to the registry
September 15, 2025
CompletedFirst Posted
Study publicly available on registry
September 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedApril 13, 2026
April 1, 2026
5 months
September 15, 2025
April 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Pulse Wave Velocity
normal level 60-100 per minutes
each week
Study Arms (2)
DASH diet group
EXPERIMENTAL22 patients will receive hypotensive drugs and High Intensity Interval Training ( HIIT) combined with DASH diet.
Comparator group
ACTIVE COMPARATOR22 patients will receive hypotensive drugs and High Intensity Interval Training ( HIIT)
Interventions
Eating vegetables, fruits, and whole grains Including fat-free or low-fat dairy products, fish, poultry, beans, nuts, and vegetable oils Limiting foods that are high in saturated fat, such as fatty meats, full-fat dairy products, and tropical oils such as coconut, palm kernel, and palm oils Limiting sugar-sweetened beverages and sweets
Eligibility Criteria
You may qualify if:
- Their age\< 35 up to 50 years old
- Both sexes.
- Controlled HTN ( stage 1,B.P 140-159 mmhg / 90-99 mmhg and stage 2, B.P 160-179 mmhg-100-109 mmhg )
- Hemodynamic stable. Able to provide informed consent
You may not qualify if:
- Uncontrolled hypertension.
- Severe HTN \<180/110 mmhg
- Renal dysfunction
- Unstable cardiac conditions
- Severe pulmonary disease that limit exercise
- Impaired cognition
- Musculoskeletal problems that made it difficult to do exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Waleed Mohamed Abdelmohsen Abdelsalalm
Minya, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2025
First Posted
September 23, 2025
Study Start
July 10, 2025
Primary Completion
December 10, 2025
Study Completion
January 1, 2026
Last Updated
April 13, 2026
Record last verified: 2026-04